Back to results
US 8,575,173 B2Granted
Piperazinyl 3-aminopyrrolidine derivatives as a CCR2 antagonists
AssigneeYang Ji Chemical Co., Ltd.
InventorsJee Woong Lim, Jong-Hoon Kim, Min-Ho Oak, Yongho Na, Youna Oh, So-Hee Kang, Jung-Ok Lee, Jung-Duk Sohn, Seung-Woo Lee
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of chemical formula 1 and having CCR2 (chemokine receptor 2) antagonistic effects, and salts or isomers thereof. These compounds are very useful for treating, preventing, or relieving rheumatoid arthritis, arteriosclerosis, multiple sclerosis, asthma, and various diseases related to CCR2. wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 is the same as defined in the specification.
Claims6
Compound having the following formula I
- wherein:
- R1 can be independently selected from the group consisting of hydrogen atom, C1-C3 alkyl, phenyl, benzyl, benzoyl, benzensulfonyl, C1-C3 alkylcarbonyl, C3-C7 cycloalkyl, the formula II, III and IV;
- R10, R11 and R12 can be independently selected from the group consisting of hydrogen atom, C1-C3 alkyl, phenyl, and benzyl;
- all benzene groups included as part of R1 can have a plurality of substituents independently selected from the group consisting of C1-C3 alkyl, C1-C2 haloalkyl, halogen atom and cyano;
- R2, R3, R4, R5, R6, R7, R8 and R9 can be independently selected from hydrogen atom and C1-C3 alkyl;
- R6 and R7, R8 and R9 can be independently selected as carbonyl group;
- wherein said halogen is selected from the group consisting of fluorine, chlorine and bromine atom.
4 more elements
Dependencies are inferred from the claim text.